M&A

VERAXA Biotech Enters a Business Combination Agreement with Voyager Acquisition Corp to Develop Cancer Therapies

VERAXA Biotech Enters a Business Combination Agreement with Voyager Acquisition Corp to Develop Cancer Therapies

Shots: VERAXA to reverse merge with Voyager, where the combined entity- "VERA...

Alumis and ACELYRIN Revise Merger Agreement, Boosting ACELYRIN Stake

Alumis and ACELYRIN Revise Merger Agreement, Boosting ACELYRIN Stake

Shots: Alumis and ACELYRIN have amended their

RadNet to Acquire iCAD for ~$103M

RadNet to Acquire iCAD for ~$103M

Shots: RadNet has entered into a definitive merger agreement to acquire iCAD in an...

Intas Pharmaceuticals Acquires Coherus BioSciences’ Udenyca Business (Biosimilar, Neulasta)

Intas Pharmaceuticals Acquires Coherus BioSciences’ Udenyca Business (Biosimilar, Neulasta)

Shots: Intas has acquired Coherus’ Udenyca business (incl. prefilled syringe...

Siemens to Acquire Dotmatics for $5.1B, Strengthening its Position in Life Science Market

Siemens to Acquire Dotmatics for $5.1B, Strengthening its Position in Life Science Market

Shots: Siemens has entered into an agreement to acquire Dotmatics for $5.1B from I...

Paratek Pharmaceuticals to Acquire Optinose for ~$330M, Expanding its Commercial Portfolio

Paratek Pharmaceuticals to Acquire Optinose for ~$330M, Expanding its Commercial Portfolio

Shots: Paratek has entered into a definitive merger agreement to acquire Optinose...

Image